Patents/Assignees

Orphai Therapeutics Inc.

2 patents in portfolio

US12611398utility2026
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
0 cites
US12171874utility2024
Rapamycin for the Treatment of Lymphangioleiomyomatosis
0 cites